Richard Douglas

Filings by Richard Douglas span 3 companies, the busiest being Novavax Inc, Maxcyte, Inc. and Aldeyra Therapeutics, Inc. Over a trading history stretching from 25 June 2021 to 20 June 2026, the count stands at 14 filings.

On the market, this insider has only ever bought: 4 purchases, €696k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 3 share grants and 7 option exercises. So far in 2026, the count stands at 1 purchase and no sales.

In size, the median ticket on the buying side is €146k. 2 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 23 June 2026: an option exercise, in Novavax Inc. The latest purchase dates back some time: it was published 212 days ago, on 20 March 2026. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.